Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up - European Society for Medical Oncology (ESMO)

This ESMO Clinical Practice Guideline provides key recommendations for managing epithelial ovarian cancer.

The guideline covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up.

Treatment and management algorithms for early and advanced disease, as well as recurrent disease, are provided.

ESMO-MCBS and ESCAT scores are given to describe the levels of evidence for treatment choices including targeted therapies.

The multidisciplinary expert author group stems from different institutions and countries in Europe, Asia and the USA.


Read full Guideline